Regulatory acceptance and use of 3R models for pharmaceuticals and chemicals: Expert opinions on the state of affairs and the way forward

M.J.W.A. Schiffelers, B. Blauboer, W.E. Bakker, S. Beken, C.F.M. Hendriksen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)41-48
JournalRegulatory Toxicology and Pharmacology
Publication statusPublished - 2014

Cite this